Literature DB >> 10709370

Patient compliance and blood pressure control on a nuclear-powered aircraft carrier: impact of a pharmacy officer.

M E Brouker1, K Gallagher, E P Larrat, R L Dufresne.   

Abstract

The impact of a pharmacy officer on patient compliance and blood pressure control on a deployed nuclear-powered aircraft carrier for a 2-week at-sea period was evaluated. Before any counseling by a pharmacy officer, 43 crewmembers on chronic medications anonymously completed a compliance questionnaire. The pharmacy officer then counseled these crewmembers. A follow-up compliance questionnaire was completed 2 weeks later. After counseling, compliance had increased 58% (p < 0.0001) from compliance measured before counseling. The pharmacy officer also initiated therapeutic interventions. Among 26 crewmembers diagnosed as hypertensive, preintervention blood pressure (BP) measurements were obtained. Ten to 14 days after the initial BP measurement, BP was remeasured. After intervention, 31% (p < 0.02) more crewmembers were at BP goal compared with before intervention. A pharmacy officer, working closely with a medical officer, improved patient compliance and blood pressure control. One problem identified was that these warships require computer software that can prospectively identify drug-drug interactions.

Entities:  

Mesh:

Year:  2000        PMID: 10709370

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  [Effect of pharmacist involvement in adherence to medications in patients with high to moderate cardiovascular risk (Study EMDADER-CV-INCUMPLIMIENTO)].

Authors:  Miguel Ángel Rodríguez Chamorro; Emilio García-Jiménez; Pedro Amariles; Alfonso Rodríguez Chamorro; Eva María Pérez Merino; Fernando Martínez Martínez; María José Faus Dader
Journal:  Aten Primaria       Date:  2011-01-05       Impact factor: 1.137

2.  Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.

Authors:  Manuel Morgado; Sandra Rolo; Miguel Castelo-Branco
Journal:  Int J Clin Pharm       Date:  2011-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.